Infectious Disease CME/CE Courses & Articles

CME/CE Courses – Update

Infectious Disease CME/CE Courses

myCMEYour search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.

Featured Courses

Final Chapter: Post-COVID-19 Fibrosis and the Role of Antifibrotic Therapy Management

Final Chapter: Post-COVID-19 Fibrosis and the Role of Antifibrotic Therapy Management | myCME

AMA PRA Category 1 Credit(s)TM
What do we know about post-ARDS fibrosis in patients who have recovered from COVID-19? In this 10-minute CME-certified vlog, leading pulmonology expert Christopher King, MD, FACP, FCCP, Director of Transplant and Advanced Lung Disease Critical Care Program at Inova Fairfax Hospital, will discuss topics such as post-ARDS fibrosis in patients who have recovered from COVID-19, the potential role of antifibrotic therapies, ongoing clinical trials
The Next Chapter: Post-Care After COVID-19 Recovery

The Next Chapter: Post-Care After COVID-19 Recovery | myCME

AMA PRA Category 1 Credit(s)TM
In this concise 15-minute CME-certified vlog, hear from leading Pulmonology expert, Imre Noth, MD, Chief of Pulmonary & Critical Care Medicine from the University of Virginia School of Medicine who will discuss long-term post-COVID-19 monitoring strategies.
Straight Talk with the Expert Surrounding COVID-19 and Your Patients with ILD

Straight Talk with the Expert Surrounding COVID-19 and Your Patients with ILD | myCME

AMA PRA Category 1 Credit(s)TM
Dr. Imre Noth summarizes what we have learned through August 2020 about COVID-19 and its implications for patients with interstitial lung disease (ILD) while providing his own front-line clinical experiences. Talking points include mitigating risks of COVID-19 in patients with ILD, strategies to help patients continue ILD treatment and supportive care, as well as strategies to differentiate post-ARDS fibrosis and ILDs.
Real World Experience from the Front Lines: COVID-19, Acute Lung Injury, and ARDS

COVID-19 Virtual Panel | myCME

AMA PRA Category 1 Credit(s)TM
This panel discussion features a pulmonologist, radiologist, and infectious disease specialist, who discuss management and treatment for COVID-19 patients that develop acute lung injury or acute respiratory distress syndrome (ARDS). The discussion synthesizes current data, protocols, and management strategies for caring for COVID-19 patients as well as post discharge monitoring.
HCV in People Who Inject Drugs: A Call to Action for Frontline Providers

HCV in People Who Inject Drugs: A Call to Action for Frontline Providers | myCME

AMA PRA Category 1 Credit(s)TM
In this activity, expert faculty will describe the epidemiologic imperative for HCV treatment as prevention within populations of people who inject drugs (PWID). The participant will learn both the importance of and tactics for HCV testing and linkage to HCV treatment. Barriers to treatment of HCV-positive PWID and outdated clinical assumptions regarding eligibility and prescribing limitations will be discussed, along with current clinical evidence for the feasibility and success of treatment.
When is Switching ART Necessary?

When is Switching ART Necessary? | myCME

AMA PRA Category 1 Credit(s)TM, CE for Pharmacists
In this CME Outfitters BriefCase, faculty will highlight a patient case that focuses on seizing opportunities to optimize and simplify treatment for patients with human immunodeficiency virus (HIV) while maintaining virologic suppression, as well as best practices for engaging patients in shared decision-making so that patient preference is always considered.

Click for More Infectious Disease Courses

Next hm-section-front in CME